BSE FMCG Sector Regulatory Filings — October 05, 2026

Consolidated revenue grew double-digits with operating profit up mid-twenties, driven by Parachute Coconut Oil (early teens volume growth) and Value Added Hair Oils (sixth consecutive quarter of 20%+ growth), while copra prices remain ~35% below peak levels, supporting margin expansion

Projected high-teens consolidated revenue growth with double-digit EBITDA growth despite El-Niño headwinds, with Indonesia and GAUM (Africa, USA, Middle East) businesses delivering strong double-digit growth, indicating successful geographic diversification

Acquired additional 24.09% stake in Satiya Nutraceuticals for ₹1,012 crore (total ₹1,392 crore for 84.09% holding), with Satiya's revenue surging from ₹155 crore in FY24 to ₹864 crore in FY26 (5.6x growth in 2 years), signaling high-conviction bet on nutraceuticals

Bought back 6,50,000 shares at ₹375.94 average price on October 5, with cumulative buyback reaching 67.72 lakh shares, demonstrating management's confidence in intrinsic value and commitment to shareholder returns

International business delivered robust teens constant currency growth led by Vietnam, Middle East, and South Africa, while Bangladesh showed only marginal sequential improvement amid high inflation, creating a differentiated growth story vs peers

Standalone business expected high-single-digit volume growth despite 100-150 bps impact from trade inventory correction, indicating strong underlying demand that will normalize once destocking ends

Saffola Oils volumes declined as company prioritized threshold profitability and rationalized select variants, a strategic trade-off that protects margins but signals competitive pressure in the edible oils segment

Board meeting scheduled for October 27, 2026 to approve Q2 FY27 results; trading window closed until October 29, suggesting potential insider activity ahead of results

Input cost pressures intensified in Q2 across crude-linked derivatives, palm oils, and other commodities after moderation in Q1, requiring calibrated pricing actions and cost management initiatives

Satiya Nutraceuticals remaining 14.09% stake to be acquired in July 2027 with base consideration up to ₹592 crore plus milestone payments, creating a defined catalyst timeline for the next 9 months

Input cost pressures intensified during Q2 FY27 across crude-linked derivatives, palm oils, and other commodities after some moderation in Q1, threatening margin trajectory if pricing actions prove insufficient

Saffola Oils volumes declined as company focused on threshold profitability and rationalized supply of select variants, indicating potential market share loss in the mass edible oils segment to competitors

Bangladesh business showed only marginal sequential improvement amid high inflation, suggesting prolonged weakness in a key international market that could drag on overall international growth

Uneven monsoon conditions and intensifying El-Niño impacted consumption, creating demand uncertainty for rural-dependent FMCG categories that could persist into H2 FY27

Trading window closed from September 21 to October 29, 2026, a 38-day closure period that may indicate material non-public information, though likely routine ahead of results

The Satiya Nutraceuticals stake acquisition is a related party transaction with founders and their relatives, requiring close scrutiny of valuation fairness despite arm's length basis

Standalone business impacted by estimated 100-150 bps from trade inventory correction, suggesting channel destocking that could persist if demand remains soft

Buyback being executed through open market route on NSE only, with no BSE or MSEI purchases, potentially limiting execution speed and price efficiency

Acquiring 24.09% stake for ₹1,012 crore implies an enterprise value of ~₹4,200 crore for Satiya Nutraceuticals, or ~4.9x FY26 revenue of ₹864 crore, a premium valuation that requires sustained high growth to justify

Sixth consecutive quarter of 20%+ growth in Value Added Hair Oils, aided by investments in mid and premium segments and enhanced direct reach through Project SETU, indicating a structural growth trend that could sustain for 3-4 more quarters

Indonesia and GAUM businesses expected to deliver strong double-digit growth, providing geographic diversification away from India's competitive market and potential margin upside from higher-margin international operations

Copra prices ~35% below peak levels, providing significant margin buffer for Parachute Coconut Oil even as other input costs rise, potentially driving operating profit growth in mid-twenties as guided

Satiya's revenue grew from ₹155 crore in FY24 to ₹864 crore in FY26 (5.6x in 2 years), and with Marico increasing stake to 84.09%, the PLIX brand could become a major nutraceutical player in India's fast-growing health-conscious market

Ongoing buyback at average price of ₹375.94 provides price support and signals management's view that stock is undervalued, with cumulative buyback of 67.72 lakh shares reducing floating supply

Board meeting on October 27 for Q2 FY27 results could provide positive surprise if beer demand recovered during the festive season, with trading window closure ending October 29 suggesting potential for material announcements

Company responding to input cost inflation with calibrated pricing actions, cost-saving initiatives, and supply-chain efficiencies, suggesting ability to protect margins better than peers if executed well

Robust teens constant currency growth in Vietnam, Middle East, and South Africa provides a hedge against India-specific risks, with these markets likely to contribute a growing share of overall revenue and profit

Remaining 14.09% stake acquisition in July 2027 with milestone-based payments creates a clear catalyst timeline, with potential for positive re-rating as Satiya's growth trajectory becomes clearer

Both Marico and GCPL reported strong performance in premium/value-added segments (Marico's Value Added Hair Oils at 20%+ growth for six quarters, GCPL's high-teens revenue growth) while mass segments (Saffola Oils volume decline) face pressure, indicating a structural shift toward premiumization in Indian FMCG

After moderation in Q1 FY27, input cost pressures intensified in Q2 across crude-linked derivatives, palm oils, and other commodities, affecting both Marico and GCPL, suggesting a sector-wide margin headwind that will require pricing actions in H2

Both Marico (Vietnam, Middle East, South Africa) and GCPL (Indonesia, GAUM) reported strong double-digit international growth, highlighting the importance of geographic diversification for Indian FMCG companies to offset domestic volatility

Marico is aggressively investing in high-growth nutraceuticals (₹1,392 crore for Satiya stake), while Emami is returning capital via buybacks, showing divergent capital allocation strategies—growth through M&A vs. shareholder returns—that investors must evaluate based on risk appetite

Despite El-Niño, uneven monsoons, and input cost inflation, both Marico (double-digit volume growth) and GCPL (high-single-digit volume growth) maintained positive volume trajectories, suggesting underlying demand remains robust in the FMCG sector

GCPL flagged 100-150 bps impact from trade inventory correction, while Marico rationalized Saffola Oils supply, indicating that channel destocking is a near-term headwind that should normalize in 1-2 quarters, creating a potential rebound opportunity

Board meeting on October 27, 2026 to approve quarterly results; watch for beer demand recovery trends and margin commentary given input cost pressures [October 27, 2026]

Expected in late October; watch for actual revenue/EBITDA vs guidance of high-teens revenue growth and double-digit EBITDA growth, and any update on El-Niño impact [Late October 2026]

Monitor revenue growth trajectory of PLIX brand in upcoming quarters; remaining 14.09% stake acquisition in July 2027 with milestone payments creates a 9-month catalyst timeline [July 2027]

Track daily buyback updates to assess execution pace; cumulative buyback of 67.72 lakh shares as of October 5, with potential to support stock price if continued aggressively [Ongoing]

Watch for any reversal of volume decline in Saffola Oils in Q3 FY27; if company can restore volumes while maintaining threshold profitability, it would signal successful navigation of competitive pressures [Q3 FY27]

Monitor crude oil and palm oil prices; any further escalation would pressure GCPL's EBITDA margins despite pricing actions, making commodity price trends a key watch item [Ongoing]

Bangladesh showed only marginal sequential improvement; watch for any acceleration in H2 FY27 as inflation moderates, as this is a key market for Marico's international growth story [H2 FY27]

With Marico and GCPL reporting resilient performance, watch for results from other FMCG peers (HUL, Nestlé, Britannia) to confirm whether premiumization and international growth are sector-wide trends or company-specific [October-November 2026]